Authors, Publishers, and Copyright Owners May Benefit from a $1.5 Billion Class Action Settlement
SEATTLE, Oct. 7, 2025 /PRNewswire/ -- JND Legal Administration A proposed class…
RTI to Host Fourth Annual Automotive Forum Featuring Industry Experts from Ansys, AMD, and Vector
SUNNYVALE, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the…
Get ready for the “BIGGEST SURPRISE” of 2025 from Gravity
SOMETHING BIG IS COMING! BANGKOK, Oct. 6, 2025 /PRNewswire/ -- Calling all gamers…
Trinasolar Vertex N Shield module wins comprehensive reliability award from TV Rheinland
CHANGZHOU, China, Sept. 30, 2025 /PRNewswire/ -- Trinasolar announced its Vertex N…
Bite Stream Secures Funding from NewSpring Capital
Bite Stream, Bite Investments' flagship software platform, strengthens its position as a…
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
September 29, 2025 19:30 ET | Source: Nxera Pharma Tokyo, Japan and…
Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital
LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma…
Abu Dhabi Art Fair 2025 to Host 140 Galleries From 35+ Countries
ABU DHABI, UAE, Sept. 29, 2025 /PRNewswire/ -- Organised by the Department…
OXCCU Raises $28m in Series B Funding to Scale Sustainable Aviation Fuel from Waste Carbon
Backed by global leaders in aviation, energy, and climate investing, OXCCU strengthens its…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
